Department of Psychiatry Faculty

Robert Rosenheck, MD Professor of Psychiatry and Epidemiology and Public Health Director, Division of Mental Health Services and Outcomes Research Northeast Program Evaluation Center/182 950 Campbell Ave West Haven, CT 06516 Fax: 203-937-3433 Email: robert.rosenheck@yale.edu

Education

1969, B.A. Harvard College
1973, M.D., University of Pennsylvania
Residency: Yale University

Research Interest

As the nationís health care systems undergo unprecedented change there is an urgent need to evaluate the effectiveness of both innovative and standard treatments as they are delivered in current practice through both experimental focused studies and large performance evaluation efforts. Current research efforts focus on cost-effectiveness evaluations; outcome measurement; systems change; and managed care in both public and private sectors.

Publications of Note

Rosenheck RA, Lam J, Morrissey JP, Calloway M, Marilyn Stolar, Randolph F, Blasinsky M, Johnsen, M, Steadman H, Cocozza J, Dennis DD, Goldman HH. Do Efforts to Improve Service Systems Integration Enhance Outcomes for Homeless Persons with Serious Mental Illness? Evidence from the ACCESS Program. Psychiatric Services. 2002:53(8):958-966

Rosenheck RA, Morrissey J, Lam J, Calloway M, Stolar M, Johnsen M, Randolph F, Blasinsky M and Goldman HH. Service delivery and community: Social capital, service systems integration, and outcomes among homeless persons with severe mental illness. Health Services Research 2001;36(4):691-710.

Rosenheck RA and Dennis D. Time-limited Assertive Community Treatment (ACT) for homeless persons with severe mental illness. Archives of General Psychiatry. 2001; 58(11):1073-1080.

Rosenheck RA (2000) Cost-effectiveness of services for homeless people with mental illness: The application of research to policy and practice. American Journal of Psychiatry 157(10):1563-1570.

Rosenheck R, Cramer J, Allan E, Erdos J, Frisman LK, Xu W, Thomas J, Henderson W, and Charney D (1999) Cost-Effectiveness of Clozapine in Patients With High and Low Levels of Hospital Use. Archives of General Psychiatry 1999; 56(6):565-572.

Rosenheck R, Tekall J, Peters J, Cramer J, Fontana A, Xu W, Thomas J, Henderson W, and Charney D (1998). Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine? Archives of General Psychiatry 55(7):618-625.

Rosenheck RA and Neale MS (1998) Cost-Effectiveness of Intensive Psychiatric Community Care for High Users of Inpatient Services. Archives of General Psychiatry 1998; 55(5):459-466.

Rosenheck RA and Seibyl CL (1998) The Experience of Black and White Veterans in a Residential Treatment and Work Therapy Program for Substance Abuse. American Journal of Psychiatry 155(8):1029-1034.

Rosenheck RA, Cramer J, Xu W, Thomas J, Henderson W, Frisman LK, Fye C, and Charney D for the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia (1997) A Comparison of Clozapine and Haloperidol in the Treatment of Hospitalized Patients with Refractory Schizophrenia, New England Journal of Medicine 337:809-815.

Rosenheck RA and Massari LM: Psychiatric inpatient care in the VA: Before, during and after DRG-based budgeting. American Journal of Psychiatry 148 (7):888-891, 1991.

Rosenheck RA and Fontana AF (1994) A Model of Homelessness Among Male Veterans of the Vietnam Generation. American Journal of Psychiatry 151:421-427

Rosenheck RA, Fontana AF, Cottrel C (1995) Effect of Clinician-Veteran Racial Pairing in the Treatment of Posttraumatic Stress Disorder. American Journal of Psychiatry 152:555-563.

Fontana A and Rosenheck RA (1997) Effectiveness and Cost of Inpatient Treatment of Posttraumatic Stress Disorder, American Journal of Psychiatry 154:758-765.

Rosenheck R, Dunn L, Peszke M, Cramer J, Xu W, Thomas J, and Charney D (1999). Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia. American Journal of Psychiatry 1999;156(1):88-93.

Druss BG and Rosenheck RA. Association Between Use of Unconventional Therapies and Conventional Medical Services. JAMA; 1999;282(7):651-656.

Druss BG, Rosenheck RA. Use of Practioner-Based Complementary Therapies by Persons Reporting Mental Conditions in the United States. Archives of General Psychiatry 2000 (7): 57:708-714.

Druss B, Bradford D, Rosenheck RA, Marciniak TA, Radford M, and Krumholz H (2000). Differences in Use of Cardiovascular Revisualization Procedures Between Individuals With and Without Mental Disorders. Journal of the American Medical Association 2000;283(4):506-11.

Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Quality of Medical Care and Excess Mortality in Older Patients with Mental Disorders. Archives of General Psychiatry 2001;58(6):565-573.

Druss BG, Rohrbaugh RM, Levinson CM, Rosenheck RA. Integrated medical care for patients with serious psychiatric illness: A randomized trial. Archives of General Psychiatry 2001;58(9):861-8.

Kashner TM, Rosenheck RA, Campinell AB, Suris A, and the CWT Study Team. Impact of Work Therapy on Health Status Among Homeless Substance Dependent Veterans. Archives of General Psychiatry. 2002;59(10):938-945.

Leslie D and Rosenheck RA. From conventional antipsychotics to atypicals and back: Dynamic processes in the diffusion of new medications. American Journal of Psychiatry 2002;159(9):1534-1540.

Sernyak MJ, Leslie D, Alarcon R, Losonczy M, Rosenheck RA. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 2002;159(4):561-66.

Sernyak M, Leslie D, Rosenheck RA. Use of System-Wide Outcomes monitoring Data to Compare the Effectiveness of Atypical Neuroleptic Medication. American Journal of Psychiatry 160(2):310-315.

Rosenheck RA, Kasprow W, Frismn LK, Liu-Mares W (in press). Cost-effectiveness of Supported Housing for Homeless Persons with Mental Illness. Archives of General Psychiatry.

Copyright © . Yale University School of Medicine, Psychiatry Department. All rights reserved.
Comments or suggestions to the site editor.

Home URL: http://info.med.yale.edu/ysm